中西医结合治疗慢性乙型肝炎肝纤维化的临床观察
 |
| 第1页 |
参见附件。
摘要: 目的 观察拉米夫定联合三甲益肝颗粒治疗慢性乙型肝炎肝纤维化的疗效。方法 将106例慢性乙型肝炎肝纤维化患者随机分为对照(30 例)、拉米夫定(32 例)、拉米夫定联合三甲益肝颗粒(44 例)治疗组, 疗程12个月。观察治疗前后血清肝纤维化指标的变化。结果 拉米夫定及联合治疗组治疗后各项血清肝纤维化指标均明显下降, 联合治疗组优于拉米夫定组。结论 拉米夫定及三甲益肝颗粒有保肝和抗肝纤维化的作用, 拉米夫定和三甲益肝颗粒联合治疗可提高疗效。
关键词: 肝纤维化；拉米夫定；三甲益肝颗粒；联合治疗
【中图分类号】R4 【文献标识码】A 【文章编号】1674-0742(2012)03(c)-0000-00
Integrative treatment of chronic hepatitis liver fibrosis in clinical observation
XIONG Fen-xia, SHEN Bao-sheng
(The Frist Teaching Hospital Of Xinxiang Medical College , Henan Weihui 453100 , China )
ABSTRACT：OBJECTIVE: Observation of the top three lamivudine treatment of chronic hepatitis B particles Yigan efficacy of liver fibrosis. METHODS: The 106 cases of liver fibrosis in chronic hepatitis B were randomly divided into control ( 30 cases)、Lamivudine (32 cases)、Lamivudine combined with the top three Yigan particles (44 cases) Treatment group，Course of 12 months .Observed before and after treatment changes in serum liver fibrosis. RESULTS: Lamivudine and the combination therapy group after treatment of serum fibrosis markers were significantly decreased, Lamivudine combination therapy group than ......
您现在查看是摘要介绍页，详见PDF附件。